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Introduction {#sec001}
============

Ambient air pollution is associated with respiratory diseases and, in some cases, mortality \[[@pone.0181106.ref001]--[@pone.0181106.ref006]\], wherein exposure to ambient PMs poses a significant risk for asthma, COPD, pneumonia and cancer\[[@pone.0181106.ref007]--[@pone.0181106.ref012]\]. In fact, the WHO has reported that ambient air pollution is responsible for 3.7 million deaths in 2012, representing 6.7% of total deaths worldwide, raising significant environmental, public health, medical and economic concerns\[[@pone.0181106.ref013],[@pone.0181106.ref014]\]. These documented impacts of ambient air pollution also highlight an urgent need for better understanding of the nature of the disease-causing pollutants and their exact impact on the occurrence of diseases, particularly for a group of common and often debilitating respiratory diseases.

While several studies have demonstrated the effects of PM~2.5~ on the number of hospital admissions for respiratory diseases\[[@pone.0181106.ref015]--[@pone.0181106.ref017]\], few reports have directly investigated the effects of PM~2.5~ on cause-specific respiratory diseases using ERVs as an indicator. Most of the epidemiologic and exposure studies on health effects have primarily focused on disease association, and while the time series and case-crossover studies exploring the delayed (or 'lagged') association between exposure and outcome have been informative, comparative analysis of the delayed associations among different diseases has been scarce. The objective of this study was thus to evaluate the time-lag and seasonal effects of air pollutants, including PM~2.5~, on the incidence of emergency cases for respiratory diseases over a four-year time frame in a metropolitan medical center, where the primary patient population came from the same geographical location. Herein, we report significant seasonal variation and differential time lag effects among three common respiratory diseases, including pneumonia, chronic obstructive pulmonary disease and asthma.

Materials and methods {#sec002}
=====================

Health data {#sec003}
-----------

The data on daily emergency department visit for respiratory disease were obtained from Wan Fang Medical Center, Taipei, Taiwan, during the period of 2012 to 2015 (1461 days). The hospital is affiliated with Taipei Medical University and is located within the metropolitan area of Taipei City, Taiwan, at Wenshan District, and has had more than 65,000 emergency visits annually. Relevant data elements included a unique patient identifier number, admission date, admission source, primary and secondary International Classification of Diseases, 9th Revision (ICD-9) diagnosis codes. In the study, we considered information on emergency hospital admissions for respiratory diseases, including visits for pneumonia (480--486), chronic obstructive pulmonary disease (491, 492, 496), and asthma (493).

Environmental data {#sec004}
------------------

Daily 24-h average concentrations of PM~2.5~, nitrogen dioxide (NO~2~) and sulfur dioxide (SO~2~) were obtained from the Environmental Protection Administration's (EPA) Taiwan Air Quality Monitoring Network (TAQMN). The hourly air pollution data collected from Gutting air quality monitoring station with distance of 4 km to Wan Fang Medical Center were utilized. The 24 h average levels of the pollutants were computed. Daily information on mean temperature was provided by the Taipei Observatory of the Central Weather Bureau.

Statistical analyses {#sec005}
--------------------

Descriptive statistics and correlation patterns between air pollutants, and meteorological factors were analyzed. The Distributed-lag model analysis was performed to study the association between the number of emergency visits and the level of pollutants at different lags, controlling for possible confounding factors, such as mean daily temperature, NO~2~ and SO~2~. Relative risk of emergency visit was calculated using a generalized additive model based on Poisson distribution allowing for over-dispersion (quasi-likelihood). For the independent variables, a natural cubic spline with 6 degrees of freedom per year was used to account for seasonal variability. Regarding the concentration of PM~2.5~, a basis function was used for the lagged variable, using a polynomial of the third degree (df = 4), assuming that the relationship between the dependent variable and the predictor was linear. We also performed separate analyses of seasonal variations, including those parameters in the spring (March-May), summer (June-August), fall (September-November) and winter (December-February) periods. All findings were presented as relative risks (RRs) of emergency visit with 95% confidence intervals (95% CI). The reference value for PM~2.5~ concentrations was set at 10 μg/m^3^. Relative risks are shown as per log-increase in PM concentrations from the reference. All analyses were conducted in R 3.2.4 and the DLNM\[[@pone.0181106.ref018]\] package were used.

Ethics approval {#sec006}
---------------

For this retrospective observational study, our IRB waived the need for consent. Also, the data was accessed anonymously. Ethics approval was granted by the Ethics Committee of Taipei Medical University---Joint Institutional Review Board. (TMU-JIRB NO: N201611011)

Results {#sec007}
=======

During the study period of a 4-year time span between 2012--2015, the total number of ERVs for respiratory diseases were 5335, in which pneumonia represented the majority (69.9%) of ERV, while ERV for two other respiratory diseases, asthma and COPD, were less prominent ([Table 1](#pone.0181106.t001){ref-type="table"}). Also, there were, on average 3.65 ERVs per day for respiratory diseases, with daily means of ~~0.58~~ 0.55, 2.55 and 0.55 ERV for asthma, pneumonia and COPD, respectively.

10.1371/journal.pone.0181106.t001

###### Daily frequency of hospital emergency visits.

![](pone.0181106.t001){#pone.0181106.t001g}

              Number of Visit   Daily Mean
  ----------- ----------------- ------------
  Total       5335              3.65
  Asthma      800               0.55
  Pneumonia   3729              2.55
  COPD        806               0.55

Based on the dataset of a stationary monitoring station within the vicinity of Wan-Fang Medical Center, the mean 24-h PM~2.5~ concentration was 21.96 μg/m^3^, ranging from 1.00 to 87.33 μg/m^3^. Higher particle mass concentrations were typically observed during winter. The descriptive statistics for the corresponding environmental data are shown in [Table 2](#pone.0181106.t002){ref-type="table"}. [Fig 1](#pone.0181106.g001){ref-type="fig"} depicts the Pearson correlation matrix for the selected variables. Results showed that the concentrations of PM~2.5~ were positively correlated with the concentrations of SO~2~ and NO~2~, with both p values less than 2.2X10^-16^, and that the pollutant parameters were significantly correlated to each other (p \< 0.001).

![Correlation matrix for ambient air pollutants in Taipei, Taiwan, 2012--2015; Temperature: °C, PM2.5: ture: aipei,ppb, SO2: ppb.](pone.0181106.g001){#pone.0181106.g001}
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###### Distribution of daily temperature, and air pollution variables in Taipei, Taiwan, 2012--2015.

![](pone.0181106.t002){#pone.0181106.t002g}

                    Min                Max     Mean    Median   SD      
  ----------------- ------------------ ------- ------- -------- ------- ------
  **Year**          Temperature (°C)   8.63    37.00   23.55    24.21   5.44
  PM2.5 (μg/m^3^)   1.00               87.33   21.96   19.71    11.60   
  NO2 (ppb)         2.38               49.88   20.14   19.36    6.73    
  SO2 (ppb)         0.82               12.53   2.70    2.47     1.18    
  **Spring**        Temperature (°C)   12.71   31.08   22.51    22.96   4.16
  PM2.5 (μg/m^3^)   3.83               63.04   26.11   24.60    11.36   
  NO2 (ppb)         9.83               49.25   23.55   22.70    7.13    
  SO2 (ppb)         0.82               9.73    2.86    2.73     1.18    
  **Summer**        Temperature (°C)   24.88   37.00   29.52    29.75   1.68
  PM2.5 (μg/m^3^)   1.92               44.00   17.14   16.25    7.72    
  NO2 (ppb)         2.38               32.04   17.34   17.95    5.20    
  SO2 (ppb)         1.08               6.62    2.71    2.64     0.98    
  **Fall**          Temperature (°C)   13.50   32.13   24.89    24.77   3.40
  PM2.5 (μg/m^3^)   1.00               54.38   19.23   17.77    10.00   
  NO2 (ppb)         3.82               45.58   17.39   17.18    5.03    
  SO2 (ppb)         0.83               9.88    2.41    2.14     1.07    
  **Winter**        Temperature (°C)   8.63    23.71   17.15    17.13   2.74
  PM2.5 (μg/m^3^)   2.00               87.33   25.41   22.92    13.85   
  NO2 (ppb)         6.41               49.88   22.29   20.78    6.81    
  SO2 (ppb)         0.95               12.53   2.83    2.51     1.41    

For the Distributed-lag model analysis, based on Poisson regression, with the three pollutants analyzed together, adjusted for temperature, we obtained their relative risks and their respective confidence intervals of 95% for ERV. The effects of PM2.5 on the risk of ERV for total respiratory diseases were found to be significant at lag day 5 with increasing risk of 1.27% \[RR: 1.026; CI: 1.001--1.051 (95%)\] ([Fig 2a](#pone.0181106.g002){ref-type="fig"}). The PM~2.5~ levels and ERVs for all three diseases demonstrated that ERVs for pneumonia and asthma were associated with the level of PM~2.5~ ([Fig 2b and 2d](#pone.0181106.g002){ref-type="fig"}). The effects of PM~2.5~ on the risk of ERV for asthma were found to be significant at lag days 1 and 2 ([Fig 2b](#pone.0181106.g002){ref-type="fig"}). At lag day 1 and 2, the risk of ERVs for asthma increased by 4.34% \[RR: 1.091; CI: 1.020--1.166 (95%)\] and 3.58% \[RR: 1.074; CI: 1.007--1.146 (95%)\], respectively, as per 10 μg/m3 increase in PM~2.5.~ Also, the effects of PM~2.5~ on the risk of ERV for pneumonia were found to be significant at lag days 5, 6 and 7 ([Fig 2d](#pone.0181106.g002){ref-type="fig"}). At lag day 5, 6 and 7, the risk of ERVs for pneumonia increased by 1.92% \[RR: 1.039; CI: 1.009--1.070 (95%)\], 2.03% \[RR: 1.041; CI: 1.009--1.075 (95%)\], and 1.82% \[RR: 1.037; CI: 1.001--1.075 (95%)\], respectively, as per 10 μg/m^3^ increase in PM~2.5~. In contrast, no significant association of ERVs was noted for any one of the three respiratory diseases with the levels of NO~2~ and SO~2~ ([S1 Fig](#pone.0181106.s001){ref-type="supplementary-material"}).

![Lag-response curve for every 10 μg/m^3^ increase of PM~2.5~ for respiratory diseases.\
(a) all three respiratory diseases, (b) asthma, (c) COPD, and (d) pneumonia.](pone.0181106.g002){#pone.0181106.g002}

When examining ERV by different seasons, an increase in PM~2.5~ concentration was associated with significant increase in ERV for asthma and COPD. In the context of asthma, a total of 800 asthma visits were analyzed, of whom 13.39% were admitted. During the spring, significantly lower frequency of admission was found as compared with those during the fall and winter. Significantly, increased risk of ERVs for asthma was noted during spring at lag days 0, 1 and 2 (17.12%, RR: 1.408, CI: 1.075--1.238; 15.30%, RR: 1.358 CI: 1.158--1.166; 11.94%, RR: 1.165, CI: 1.004--1.121; [Fig 3](#pone.0181106.g003){ref-type="fig"}). Interestingly, no significant association of ERVs was found for asthma during spring with the levels of NO~2~ or SO~2~ ([S2 Fig](#pone.0181106.s002){ref-type="supplementary-material"}).

![Relative risks of ERVs for asthma with an increase of 10 μg/m^3^ in PM~2.5~ in different seasons.\
(a) Spring, (b) Summer, (c) Fall and (d) Winter.](pone.0181106.g003){#pone.0181106.g003}

When the dataset was stratified by age, it was noted that the patients with asthma who were older than 75 years had significant higher admission rate, and for asthma patients of younger than 75 years of age, a 10 μg/m^3^ increase in PM~2.5~ during spring was significantly associated with ERV at lag days 0, 1, 2 and 3 (16.69%, RR: 1.396, CI: 1.007--1.936; 19.31%, RR: 1.471, CI: 1.214--1.783; 17.33%, RR: 1.414, CI: 1.176--1.701; 12.22%, RR: 1.277, CI: 1.063--1.534; [Fig 4a](#pone.0181106.g004){ref-type="fig"}). PM~2.5~ appeared to show no significant effect on asthma patients of older than 75 years of age during spring ([Fig 4b](#pone.0181106.g004){ref-type="fig"}).

![Lag-response curve for every 10 μg/m^3^ increase of PM~2.5~ for asthmatic patients stratified by age.\
(a) Asthmatic patients who were \< 75 years old and (b) Asthmatic patients who were 75 years of age or older.](pone.0181106.g004){#pone.0181106.g004}

As for COPD, a total of 806 COPD visits were analyzed, of whom 40.81% were admitted, and no significant difference was seen for the frequency of admission among different seasons. During summer, significant associations at lag days 3, 4, 5 and 6 were found between PM~2.5~ and ERV for COPD (14.19%, RR: 1.328, CI: 1.045--1.688; 14.86%; RR: 1.346, CI: 1.082--1.676; 13.81%; RR: 1.318, CI: 1.072--1.621; 11.89%; RR: 1.269, CI: 1.04614--1.587, respectively; [Fig 5](#pone.0181106.g005){ref-type="fig"}). During summer, there was no significant association between the level of NO~2~ and ERV for COPD; also, SO~2~ did not appear to be a risk factor ([S3 Fig](#pone.0181106.s003){ref-type="supplementary-material"}).

![Relative risks of ERVs for COPD with an increase of 10 μg/m³ in PM~2.5~ at different seasons.\
(a) Spring, (b) Summer, (c) Fall and (d) Winter.](pone.0181106.g005){#pone.0181106.g005}

The patients with COPD were also divided into two age groups: ≥ 75 years of age and\<75 years of age. More than half of the patients with COPD who visited the emergency department were older than 75 years of age. By comparison with winter, during summer, a higher percentage of COPD patients who were older than 75 years visited the emergency department. Also, the patients with COPD who were older than 75 years had significant higher admission rate. For COPD patients of younger than 75 years of age, a 10 μg/m^3^ increase in PM~2.5~, during summer, was significantly associated with ERV at lag days 3, 4 and 5. (26.66%, RR: 1.704, CI: 1.104--2.632; 26.99%; RR: 1.716, CI: 1.151--2.557; 24.09%; RR: 1.619, CI: 1.111--2.360; [Fig 6a](#pone.0181106.g006){ref-type="fig"}). PM~2.5~ didn't show any significant effect on COPD patients of older than 75 years of age during summer ([Fig 6b](#pone.0181106.g006){ref-type="fig"}).

![Lag-response curve for every 10 μg/m^3^ increase in PM~2.5~ for patients with COPD in different age groups.\
(a) COPD patients who were \< 75 years old and (b) COPD patients who were 75 years of age or older.](pone.0181106.g006){#pone.0181106.g006}

Discussion {#sec008}
==========

In this study, we attempted to identify the relationship between the level of ambient air pollution, including the level of PM~2.5~, and ERV for three different respiratory diseases in a four-year time series study. While most of previous epidemiologic studies used number of hospital admissions as an indicator as an acute exacerbation indicator, the number of ERVs would be more relevant to disease exacerbation and would be more pertinent to investigate the time lag effects. Our study showed significant seasonal variation and differential time lag effects on ERV for asthma, COPD and pneumonia. In this study, our findings reveal associations between PM~2.5~ and ERVs for asthma and pneumonia. However, when the analyses were separated by season, increased risks of ERV for asthma and COPD with increasing ambient PM~2.5~ levels were noted in the spring and in the summer, respectively.

Several studies have demonstrated the effects of PM~2.5~ on the number of hospital admissions due to pneumonia, COPD and asthma \[[@pone.0181106.ref008],[@pone.0181106.ref019],[@pone.0181106.ref020]\]. Nevertheless, few studies have investigated the effects of PM~2.5~ on cause-specific respiratory diseases using ERV as a morbidity indicator. Most studies, which used ERV as a morbidity indicator, were conducted in western developed countries and there is still a need to assess the health effects of PM~2.5~ exposure in Asia countries. Further, this study is in accordance with previous findings of adverse effects of PM~2.5~ on asthma, COPD, and pneumonia admissions on both warm and cool days in Taipei \[[@pone.0181106.ref008],[@pone.0181106.ref019],[@pone.0181106.ref020]\]. However, our data only revealed the significant association during the specific season. In this study, the PM~2.5~ level was found to be associated with asthma ERV during spring, COPD ERV during summer and pneumonia during all 4 seasons. Interestingly, higher particle matter concentrations were observed during winter. This seasonal difference has also been reported in Kaohsiung, Taiwan. The prior work by Hwanh et al. \[[@pone.0181106.ref021]\] assessed the influence of PM~2.5~ on hospital admissions for COPD in Kaohsiung, and observed an increased risk of COPD admissions associated with ambient PM~2.5~ levels on cool days. The difference in the effect of PM~2.5~ on ERV for cause-specific respiratory diseases in different seasons and location might be due to the variations in PM~2.5~ constituents. PM is formed by different compounds. Depending on sources, PM composition can be different among cities \[[@pone.0181106.ref022]\] and shows obviously seasonal patterns, and some components of PM also show seasonal patterns. \[[@pone.0181106.ref023]--[@pone.0181106.ref025]\].

In this study, PM~2.5~ showed different lag effect on different diseases. The level of PM~2.5~ was associated with asthma exacerbation ERV at lag 0 day, while it had an impact on COPD ERV at the lag 3 day. Moreover, the pneumonia ERV also showed an association with the level of PM~2.5~ at the lag 5 day. The different lag effect suggests that the different underlying mechanism of the diseases can be elicited by PM~2.5~. The mechanisms of the adverse effects of PM~2.5~ on the respiratory system have been suggested including: oxidative stress and altered immunity. \[[@pone.0181106.ref026]\] Several studies have suggested that PM~2.5~ can induce acute oxidative stress and inflammation in respiratory system. \[[@pone.0181106.ref027]--[@pone.0181106.ref029]\] A resent research demonstrated that the pulmonary inflammation and oxidative stress pathway is the first to respond to PM~2.5~ exposure. \[[@pone.0181106.ref006]\] Moreover, exposure of PM~2.5~ also can suppress phagocytosis of bacteria \[[@pone.0181106.ref030],[@pone.0181106.ref031]\] and enhance pneumococcal adhesion to epithelial cells. \[[@pone.0181106.ref032]\] Also, the inhaled PM can induce direct oxidative stress and changes to growing conditions of respiratory microbiome. Disrupting the community structure of the microbiome could then result in downstream respiratory tract infection.\[[@pone.0181106.ref033]\] In our study, the increased level of PM~2.5~ was associated with asthma exacerbation at early lag day. The results suggest that, in asthma exacerbation, the PM~2.5~ may function as a trigger to directly induce asthma attack. In terms of AECOPD and pneumonia ERV, the positive associations with PM~2.5~ concentrations were at later lag day. The data suggests that PM~2.5~ might have a priming effect on respiratory tract and precondition the lung for further infection or inflammatory triggers.

For age subgroup analysis, a clear positive association between PM and respiratory disease was not evident overall in our study. There was an increase in AECOPD ERVs in patients who were younger than 75 years, with increase in PM~2.5~ in the summer. Likewise, for the \<75 years of age group, ERV for asthma exacerbation were positively associated with PM~2.5~ during the spring. People who are younger tend to spend more time outdoor, which might explain the positive effects of PM~2.5~ exposures in younger patients.

Several limitations of the current study are clearly evident. This includes the possibility of measurement error, an inherent limitation of epidemiology studies using air pollution measurements from fixed air monitoring sites. Previous research has raised a question about using stationary PM data might lead to diminishing the accuracy of exposure-response estimates compared to personal exposures. \[[@pone.0181106.ref034]\] In addition, by comparing with other studies, our population size of the study area was relatively small. However, the problem could be solved by using a longer study period. A pervious study demonstrated that the power of a time-series study of the acute health effects of air pollution can be increased by increasing either the mean daily count of the outcome or the time-series length. \[[@pone.0181106.ref035]\] Our current data suggested that the composition of PM~2.5~ might play a stronger role in disease pathophysiology than the concentration of PM. Also, PM might influence the disease via different mechanisms and cause different lag effects. The majority of the epidemiology studies used PMs as air pollution indicators and combined the data of multiple cities without analyzing the composition of PM. This type of study design might blunt the sensitivity of epidemiologic studies for detecting effects of air pollution on the respiratory disease. In conclusion, our study provides evidence that PM~2.5~ can increase the risk of respiratory ERVs, specifically for asthma, AECOPD and pneumonia.
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###### Lag-response curve for various diseases as indicated, with a 10-unit increase of NO~2~ (panel a through c) and SO~2~ (panel d to f).
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###### Relative risks of ERVs for asthma with an increase of (a) 10 ppm of NO~2~ and (b) of 1 ppb of SO~2~ during the Spring season.
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Click here for additional data file.

###### Relative risks of ERVs for COPD with an increase of (a) 10 ppm of NO~2~ and (b) of 1 ppb of SO2 during the Summer season.
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Click here for additional data file.

###### The data set underlying the findings in our study in the manuscript.

(TXT)

###### 

Click here for additional data file.
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